Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…
Entos announced selection of lead candidates for pan-Coronavirus Fusogenix DNA vaccine and $42 million award
On Jun. 25, 2020, Entos Pharmaceuticals announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA…
University of British Columbia received $14 million in federal funding for COVID-19 research
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
Moderna and Catalent announced collaboration for fill-finish manufacturing of Modernaï¾’s COVID-19 vaccine candidate
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Modernaï¾’s mRNA-based COVID-19 vaccine…
LabCorp launched new neutralizing antibody test
On Jun. 25, 2020, LabCorpï¾® announced the launch of a new test that can be used to assess…
Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
Sinovac received approval from China for its quadrivalent influenza vaccine
On Jun. 24, 2020, Sinovac Biotech announced the China National Medical Products Administration (NMPA) issued a product license…
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
Texas A&M researchers testing COVID-19 vaccine candidates for iBio
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
Universal mosquito vaccine tested
On Jun. 23, 2020, the NIH announced it had tested a ﾓuniversal mosquito vaccineï¾” known as AGS-v. It…
Sanofi and Translate Bio expanded collaboration and license agreement to develop mRNA vaccines for infectious diseases
On Jun. 23, 2020, Sanofi and Translate Bio announced they had agreed to expand their existing 2018 collaboration…
Intranasal immunization with Intravaccï¾’s experimental whooping cough vaccine confered broad protection
On Jun. 22, 2020, Intravacc announced promising results of a preclinical study with its experimental whooping cough vaccine…
Pfizer announced start of four phase 3 clinical trials for investigational vaccines
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals began clinical trials
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
Dynavax announced first participants dosed in phase 1 clinical trial evaluating Clover Biopharma’s COVID-19 S-Trimer vaccine candidate with CpG 1018 adjuvant
On Jun. 19, 2020, Dynavax Technologies announced the first participants were dosed in the Phase 1 clinical trial…
Tonix Pharma and Southern Research announced expansion of COVID-19 vaccine collaboration
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
Oxford University and Bvlgari announced collaboration to fight COVID-19 and future pandemics
On Jun. 17, 2020, Bvlgari, the Italian luxury brand, announced plans to support research into COVID-19 and vaccine…
CureVac received regulatory approval from German and Belgian authorities to initiate phase 1 clinical trial of its SARS-CoV-2 vaccine candidate
On Jun. 17, 2020, CureVac announced that the German Health Authority Paul-Ehrlich-Institute and the Belgian Federal Agency for…
Pneumonia vaccine price dropped dramatically for lower-income countries thanks to the Gavi pneumococcal Advance Market Commitment
On Jun. 16, 2020, lower-income countries across the world have access life-saving pneumococcal conjugate vaccines, which protect against…
Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
AstraZeneca to supply Europe with up to 400 million doses of Oxford Universityï¾’s vaccine at no profit
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeï¾’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
Sinovac announced positive preliminary results of phase I/II clinical trials for inactivated vaccine candidate against COVID-19
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyï¾’s…
Sinovac and Butantan joined efforts to advance clinical development of an inactivated vaccine for COVID-19 to phase III
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
Emergent BioSolutions signed agreement to be US manufacturing partner for AstraZenecaï¾’s COVID-19 vaccine candidate
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
Johnson & Johnson announced acceleration of its COVID-19 vaccine candidate with phase 1/2a clinical trial
On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…
Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…
Unique biorepository stores samples from Alberta COVID-19 patients for future research
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
The UK Global Vaccine Summit secured $74 billion in funding to support global vaccine supply and immunisation
On Jun. 5, 2020, the UK thelped secure $7.4 billion in funding to support global vaccine supply and…